Active, Not Recruiting Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer NCT03587662 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
